{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-061645","form_type":"8-K","ticker":null,"cik":"0001121702","company_name":"YIELD10 BIOSCIENCE, INC.","filed_at":"2024-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.356524+00:00","generated_at":"2026-06-01T22:36:26.183969+00:00","sec_items":["3.01","8.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Yield10 Bioscience receives final Nasdaq delisting notice; trading to OTC Markets May 16","bullets":["Failed to maintain minimum stockholders' equity of $2.5M required by Nasdaq Listing Rule 5550(b)(1).","Nasdaq trading suspended at open on May 16, 2024; shares will trade on OTC Markets under symbol YTEN.","Company does not plan to appeal the delisting determination by the Nasdaq Hearings Panel.","Business operations expected unaffected; company exploring strategic opportunities including Camelina development."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-061645","json":"https://secwatch.observer/filing/0001104659-24-061645.json","markdown":"https://secwatch.observer/filing/0001104659-24-061645.md","text":"https://secwatch.observer/filing/0001104659-24-061645.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1121702/000110465924061645/0001104659-24-061645-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1121702/000110465924061645/tm2414256d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T22:36:26.183969+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"194275178226e8c6221f307e341f4c3cf63d4c69","claim":"YIELD10 BIOSCIENCE, INC. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"e Commission (“SEC”), which would remove the Company’s common stock from listing and registration on Nasdaq. As previously reported, on May 18, 2023, the Staff of the Nasdaq informed the Company that it did not comply with the minimum stockholders’ equity requirement pursuant to Nasdaq Listing Rule 5550(b)(1) (the “Stockholders’ Equity Requirement”). The Staff granted the Company’s request for an extension until September 30, 2023, which was subsequently extended until November 14, 2023, to comply with Rule 5550(b)(1). On November 15, 2023, we received a notice from Nasdaq of the Staff’s deter","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1121702/000110465924061645/0001104659-24-061645-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"delisting notice"},{"label":"Deficiency","value":"stockholders equity"},{"label":"Rules","value":"5550(b)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}